Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography in Patients With Premature Coronary Artery Disease: a Randomized Controlled Trial

NCT06520904 is registered in ClinicalTrials.gov with First Affiliated Hospital of Xinjiang Medical University as lead sponsor.

NCT NCT06520904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06520904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography in Patients With Premature Coronary Artery Disease: a Randomized Controlled Trial
Lead sponsor
First Affiliated Hospital of Xinjiang Medical University
Phase
Phase 4
Overall status
Recruiting
Start date
July 1, 2024
Completion date
December 31, 2026
Enrollment
396 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, optical coherence tomography